Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
CM

CHARLES MICHAELS

CAPITOL COUNSEL LLC · Washington, DC
Registered · LDAActive
Request introduction →Claim this profile →

At a glance

Works on
Health IssuesMedicare/MedicaidTaxation/Internal Revenue CodeMedical/Disease Research/Clinical LabsBudget/AppropriationsFinancial Institutions/Investments/SecuritiesScience/TechnologyBankingVeteransEducationGovernment IssuesLaw Enforcement/Crime/Criminal JusticeManufacturingPharmacy
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
CAPITOL COUNSEL LLC
Washington, DC · current
Government experience
Chief of Staff
Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint.
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
32
past 12 months
Filings
33
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Food & Drug Administration (FDA)Executive Office of the President (EOP)Federal Trade Commission (FTC)Veterans Affairs, Dept of (VA)

Specific issues

Issues regarding the District of Columbia criminal justice system and DC Home Rule. H.R.4922 - D.C. Criminal Reforms to Immediately Make Everyone Safe Act of 2025; H.R. 5214, the District of Columbia Cash Bail Reform Act, H.R. 5107, the CLEAN DC Act, H.R. 5103, the the Make the District of Columbia Safe and Beautiful Act, H.R. 5525, the Stop DC CAMERA Act, H.J.Res.142, disapproving the action of the District of Columbia Council in approving the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025, and HR 5179, the District of Columbia Attorney General Appointment Reform Act.
Law Enforcement/Crime/Criminal Justice · 2026 Q1
Legislative issues related to Medicare Part B.
Medicare/Medicaid · 2026 Q1
Issues regarding approved and pipeline products, and related policy.
Medical/Disease Research/Clinical Labs · 2026 Q1
Issues regarding approved and pipeline products, and related policy. 340 program issues.
Health Issues · 2026 Q1
General monitoring of tax-related issues.
Taxation/Internal Revenue Code · 2026 Q1
Issues regarding extension of Medicare Add-on Payments, workforce shortages, balance billing and surprise medical billing reform.
Medicare/Medicaid · 2026 Q1

Clients

COUNCIL OF THE DISTRICT OF COLUMBIA
2026 · 1 filing
$██,███ / qtrFree in beta
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
2026 · 1 filing
$██,███ / qtrFree in beta
BRISTOL-MYERS SQUIBB
2026 · 1 filing
$██,███ / qtrFree in beta
CAPITAL ONE FINANCIAL CORP.
2026 · 1 filing
$██,███ / qtrFree in beta
AMERICAN AMBULANCE ASSOCIATION
2026 · 1 filing
$██,███ / qtrFree in beta
AMERICAN ACADEMY OF OPHTHALMOLOGY
2026 · 1 filing
$██,███ / qtrFree in beta
AMERICAN ACADEMY OF DERMATOLOGY
2026 · 1 filing
$██,███ / qtrFree in beta
BLUE EARTH DIAGNOSTICS, INC.
2026 · 1 filing
$██,███ / qtrFree in beta
LENOVO (UNITED STATES) INC.
2026 · 1 filing
$██,███ / qtrFree in beta
IPSEN BIOPHARMACEUTICALS, INC.
2026 · 1 filing
$██,███ / qtrFree in beta
GENENTECH
2026 · 1 filing
$██,███ / qtrFree in beta
BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.)
2026 · 1 filing
$██,███ / qtrFree in beta
AMGEN INC.
2026 · 1 filing
$██,███ / qtrFree in beta
ZAI LAB (US) LLC
2026 · 1 filing
$██,███ / qtrFree in beta
PCCA, INC.
2026 · 1 filing · engagement ended
$██,███ / qtrFree in beta
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA)
2026 · 1 filing
$██,███ / qtrFree in beta
MADRIGAL PHARMACEUTICALS, INC.
2026 · 2 filings
$██,███ / qtrFree in beta
AMICUS THERAPEUTICS, INC.
2026 · 1 filing
$██,███ / qtrFree in beta
AMERICAN BANKERS ASSOCIATION HSA COUNCIL
2026 · 1 filing
$██,███ / qtrFree in beta
PBM ACCOUNTABILITY PROJECT
2026 · 1 filing
$██,███ / qtrFree in beta
NATIONAL COUNCIL OF NONPROFITS
2026 · 1 filing
$██,███ / qtrFree in beta
LUNDBECK PHARMACEUTICALS LLC
2026 · 1 filing
$██,███ / qtrFree in beta
DISC MEDICINE
2026 · 1 filing
$██,███ / qtrFree in beta
CONTINUUS PHARMACEUTICALS
2026 · 1 filing
$██,███ / qtrFree in beta
AMERICAN PHYSICAL THERAPY ASSOCIATION
2026 · 1 filing
$██,███ / qtrFree in beta
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS
2026 · 1 filing
$██,███ / qtrFree in beta
TEMPUS LABS, INC.
2026 · 1 filing
$██,███ / qtrFree in beta
NEUROCRINE BIOSCIENCES, INC.
2026 · 1 filing
$██,███ / qtrFree in beta
GLAXOSMITHKLINE LLC
2026 · 1 filing
$██,███ / qtrFree in beta
SANTANDER HOLDINGS USA, INC.
2026 · 1 filing
$██,███ / qtrFree in beta
NATIONAL ASSOCIATION OF REALTORS
2026 · 1 filing
$██,███ / qtrFree in beta
ADP LLC
2026 · 1 filing
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings14
2026 Q1
COUNCIL OF THE DISTRICT OF COLUMBIA
Q1lda.gov →
2026 Q1
CAPITAL ONE FINANCIAL CORP.
Q1lda.gov →
2026 Q1
LENOVO (UNITED STATES) INC.
Q1lda.gov →
2026 Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
Q1lda.gov →
2026 Q1
GENENTECH
Q1lda.gov →
2026 Q1
IPSEN BIOPHARMACEUTICALS, INC.
Q1lda.gov →
2026 Q1
AMERICAN AMBULANCE ASSOCIATION
Q1lda.gov →
2026 Q1
BRISTOL-MYERS SQUIBB
Q1lda.gov →
2026 Q1
AMERICAN ACADEMY OF OPHTHALMOLOGY
Q1lda.gov →
2026 Q1
AMERICAN ACADEMY OF DERMATOLOGY
Q1lda.gov →
2026 Q1
BLUE EARTH DIAGNOSTICS, INC.
Q1lda.gov →
2026 Q1
MADRIGAL PHARMACEUTICALS, INC.
Q1lda.gov →
2026 Q1
ZAI LAB (US) LLC
Q1lda.gov →
2026 Q1
AMGEN INC.
Q1lda.gov →